business
Popular antidepressant recalled over high levels of a cancer-causing compound
By Danielle Abreu at NBC 5 Dallas-Fort Worth (KXAS) - Top Stories
· June 19, 2026
· 1 min read
A popular antidepressant is being recalled because they may contain high levels of a cancer-causing compound.
The New-Jersey based drug company Breckenridge Pharmaceuticals is recalling bottles of the prescription drug duloxetine, a generic version of Cymbalta. The medication is used to treat ...
Key takeaway The New-Jersey based drug company Breckenridge Pharmaceuticals is recalling bottles of the prescription drug duloxetine, a generic version of Cymbalta.
Why this matters in Frisco News
For Frisco residents who take duloxetine, this recall is a pressing concern, particularly given the medication's widespread use to treat depression, anxiety, and fibromyalgia. The fact that the recalled capsules were distributed nationwide means that local pharmacies and healthcare providers may have dispensed the affected lots to patients in the area. As a result, Frisco doctors and pharmacists will likely be fielding questions from concerned patients about what to do next. The recall also underscores the need for vigilant monitoring of prescription medications in the community, to ensure that patients are not unknowingly exposed to potentially harmful compounds. With many Frisco residents relying on duloxetine to manage their mental health, the recall's impact will be felt locally, and patients will be looking to their healthcare providers for guidance on how to proceed.
About this story
Original reporting by NBC 5 Dallas-Fort Worth (KXAS) - Top Stories . Frisco News surfaces reporting from trusted publishers and adds local editorial context so readers can quickly understand what a story means for their community. We attribute every source, link to the original report, and follow a documented editorial standards policy. To understand how stories are selected and reviewed, read our about page .
For the complete original report, visit NBC 5 Dallas-Fort Worth (KXAS) - Top Stories . Have a tip or correction? Contact our newsroom .
Category: business ·
Published: June 19, 2026 ·
Source: NBC 5 Dallas-Fort Worth (KXAS) - Top Stories ·
Reading time: 1 min
Get more Frisco News stories like this
Free weekly briefing covering business and other local news. Curated by our editorial team. No spam.
By subscribing you agree to our privacy policy . Unsubscribe anytime.
Frequently asked about this story
What is this story about? A popular antidepressant is being recalled because they may contain high levels of a cancer-causing compound.
The New-Jersey based drug company Breckenridge Pharmaceuticals is recalling bottles of the prescription drug duloxetine, a generic version of Cymbalta. The medication is used to treat ...
When was this published? This article was first published on June 19, 2026 by NBC 5 Dallas-Fort Worth (KXAS) - Top Stories and curated for Frisco News readers.
Who reported this story? This story was reported by Danielle Abreu at NBC 5 Dallas-Fort Worth (KXAS) - Top Stories. To learn more about how Frisco News selects and reviews stories, see our editorial standards .
Where can I find related coverage? See more business coverage from Frisco News, or browse our daily briefing and topic hubs .
← Back to all news
More business →
Today’s briefing
Subscribe to newsletter